Biocon is building capability “to take advantage of what could be a very, very strategic peptide opportunity with GLPs at the center,” Group Chief Executive Officer Peter Bains told analysts ...

February 1, 2025 India's Biocon plans IPO for biosimilars business by March 2026 Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for ...

Biocon Foundation marks 20 years of transforming lives with slew of healthcare initiatives: Our Bureau, Bengaluru Tuesday, March 4, 2025, 14:15 Hrs [IST] Biocon Foundation, the Co ...

Biocon Biologics has commercialized eight biosimilars in key emerging markets and advanced markets like U.S., Europe, Australia, Canada, and Japan.It has a pipeline of 12 biosimilar assets under ...